Table of Contents

company-logo

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot–Marie–Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Addex Therapeutics Dividend Announcement

• Addex Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Addex Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Addex Therapeutics Dividend History

Addex Therapeutics Dividend Yield

Addex Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Addex Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Addex Therapeutics Financial Ratios

P/E ratio123.07
PEG ratio1.40
P/B ratio60.13
ROE92.06%
Payout ratio0.00%
Current ratio4.59
Quick ratio4.59
Cash Ratio3.77

Addex Therapeutics Dividend FAQ

Does Addex Therapeutics stock pay dividends?
Addex Therapeutics does not currently pay dividends to its shareholders.
Has Addex Therapeutics ever paid a dividend?
No, Addex Therapeutics has no a history of paying dividends to its shareholders. Addex Therapeutics is not known for its dividend payments.
Why doesn't Addex Therapeutics pay dividends?
There are several potential reasons why Addex Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Addex Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Addex Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Addex Therapeutics a dividend aristocrat?
Addex Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Addex Therapeutics a dividend king?
Addex Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Addex Therapeutics a dividend stock?
No, Addex Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Addex Therapeutics stocks?
To buy Addex Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Addex Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.